Select Page

Screening of Drug Candidates

Home 9 Pharma 9 Development 9 Screening of Drug Candidates

Predictive high throughput screening of new active substances, including predicting biological effects and identifying structural alerts, is key to successful drug discovery.

SAXOCON provides you with a range of computer-based models to identify structural alerts and predict biological effects, including:

  • Established and validated structure-activity-relation (QSAR) models
  • Customised QSAR modelling based upon your own data library
  • Preliminary early ICH M7 classification of mutagenic impurities
  • Read-across methods
  • Expert interpretation of the readout

Why choose us?

SAXOCON services for pharmaceutical development give you access to:

  • Extensive experience with state-of-the-art safety assessments of pharmaceutical products according to international standards and regulatory guidelines
  • Best-in-class experience in using computational toxicology, including the modelling of biological effects based on chemical structure
  • Smart, cost-effective test strategies that bring your products to market in a timely manner


SAXOCON compiles all documentation in an expert statement for use to support your candidate selection process.